BK Virus and Bladder Cancer in Kidney Transplant Recipients
Author Information
Author(s): Roberts I S D, Besarani D, Mason P, Turner G, Friend P J, Newton R
Primary Institution: John Radcliffe Hospital, Oxford, UK
Hypothesis
Does BK virus play a role in the development of urothelial carcinoma in renal transplant recipients?
Conclusion
The study found that BK virus infection is not commonly associated with urothelial carcinoma in transplant recipients, although it may play a role in some cases.
Supporting Evidence
- The study found no positivity for PV T-Ag in urothelial carcinomas from 20 non-transplant patients.
- Out of 10 transplant recipients with urothelial carcinoma, only one showed strong nuclear staining for PV T-Ag.
- The presence of PV T-Ag in one patient might suggest a possible role in tumorigenesis in that specific case.
Takeaway
This study looked at whether a virus called BK virus causes bladder cancer in people who have had kidney transplants. They found that it doesn't usually cause cancer, but it might in some cases.
Methodology
The study involved immunostaining tumor tissue for PV T-Ag from renal transplant recipients with urothelial carcinoma and comparing it to a control group of non-transplant patients.
Limitations
The study had a small sample size and did not perform BKV-specific PCR to confirm the presence of the virus.
Participant Demographics
The mean age of transplant recipients with urothelial carcinoma was 58 years, with a male to female ratio of 2:6.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website